Literature DB >> 29981824

Silver nanoparticle functionalized CS-g-(CA-MA-PZA) carrier for sustainable anti-tuberculosis drug delivery.

Rajendran Amarnath Praphakar1, Murugaraj Jeyaraj2, Mukhtar Ahmed3, Subbiah Suresh Kumar4, Mariappan Rajan5.   

Abstract

Recently, drug functionalized biodegradable polymers have been appreciated to be imperative to fabricate multi-drug delivery nanosystems for sustainable drug release. In this work, amphiphilic chitosan-grafted-(cetyl alcohol-maleic anhydride-pyrazinamide) (CS-g-(CA-MA-PZA)) was synthesized by multi-step reactions. The incorporation of rifampicin (RF) and entrapment of silver nanoparticles (Ag NPs) on CS-g-(CA-MA-PZA) polymer was carried out by dialysis technique. From the FT-IR experiment, the polymer modification, incorporation of drugs and the entrapment of Ag NPs on micelles were confirmed. The surface morphology of Ag NPs, polymeric system and drug loaded micelles was described by SEM, TEM and AFM techniques. In addition, the controlled release behaviour of CS-g-(CA-MA-PZA) micelles was studied by UV-Vis spectroscopy. In vitro cell viability, cell apoptosis and cellular uptake experiments shows that multi-drug delivery system could enhance the biocompatibility and higher the cytotoxicity effect on the cells. Since the prepared amphiphilic polymeric micelles exhibit spotty features and the system is a promising strategy for a novel candidate for immediate therapeutically effects for alveolar macrophages.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alveolar macrophages; Polymeric micelles; Silver nanoparticle

Mesh:

Substances:

Year:  2018        PMID: 29981824     DOI: 10.1016/j.ijbiomac.2018.07.008

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  7 in total

1.  The Effects Study of Isoniazid Conjugated Multi-Wall Carbon Nanotubes Nanofluid on Mycobacterium tuberculosis.

Authors:  Shahab Zomorodbakhsh; Yasamin Abbasian; Maryam Naghinejad; Mojgan Sheikhpour
Journal:  Int J Nanomedicine       Date:  2020-08-13

2.  Recent Developments in Drug Delivery for Treatment of Tuberculosis by Targeting Macrophages.

Authors:  Anirudh Gairola; Aaron Benjamin; Joshua D Weatherston; Jeffrey D Cirillo; Hung-Jen Wu
Journal:  Adv Ther (Weinh)       Date:  2022-03-09

Review 3.  Nanotechnology in drug and gene delivery.

Authors:  Selma Hamimed; Marwa Jabberi; Abdelwaheb Chatti
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-05-04       Impact factor: 3.195

4.  A promising drug delivery candidate (CS-g-PMDA-CYS-fused gold nanoparticles) for inhibition of multidrug-resistant uropathogenic Serratia marcescens.

Authors:  Ping Shi; Rajendran Amarnath Praphakar; Sadhasivan Deepa; Kannan Suganya; Prashant Gupta; Riaz Ullah; Ahmed Bari; Marudhamuthu Murugan; Mariappan Rajan
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

Review 5.  Nanostructures for drug delivery in respiratory diseases therapeutics: Revision of current trends and its comparative analysis.

Authors:  Luis Ángel Ibarra-Sánchez; Ana Gámez-Méndez; Manuel Martínez-Ruiz; Erik Francisco Nájera-Martínez; Brando Alan Morales-Flores; Elda M Melchor-Martínez; Juan Eduardo Sosa-Hernández; Roberto Parra-Saldívar; Hafiz M N Iqbal
Journal:  J Drug Deliv Sci Technol       Date:  2022-03-05       Impact factor: 3.981

Review 6.  Adaptive changes induced by noble-metal nanostructures in vitro and in vivo.

Authors:  Qianqian Huang; Jinchao Zhang; Yuanyuan Zhang; Peter Timashev; Xiaowei Ma; Xing-Jie Liang
Journal:  Theranostics       Date:  2020-04-27       Impact factor: 11.556

Review 7.  Nano-based anti-tubercular drug delivery: an emerging paradigm for improved therapeutic intervention.

Authors:  Bushra Nabi; Saleha Rehman; Sumit Aggarwal; Sanjula Baboota; Javed Ali
Journal:  Drug Deliv Transl Res       Date:  2020-08       Impact factor: 5.671

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.